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Abstract OBJECTIVES: Fatty acids play a role in development and progression of colon 
cancer. The aim of this study was to assess the relation between tissue fatty acids 
(saturated fatty acids, unsaturated fatty acids, the ratio of C18 to C18:1 - index of 
fatty acids saturation, SI), colorectal tumor localization and disease progression. 
METHODS AND RESULTS: Total of 49 patients (14 with proximal colon, 13 
with distal colon and 22 with rectal tumor localization) were studied. One year 
after surgery 24 patients had the disease progression. Tissue levels of saturated 
fatty acids and unsaturated fatty acids were measured before surgery by gas-
chromatography. These fatty acids were determined in cancerous tissue (CA) and 
non-cancerous tissue (NCA). The most significant differences in the mean values 
of fatty acids of phospholipids between CA and NCA in patients with proximal 
tumor localization were noted. The mean value of C18 was significantly lower 
while C18:1 was significantly higher in CA as compared to NCA in patients with-
out disease progression (p<0.02; p<0.03; respectively). SI was significantly lower 
in CA as compared to NCA only in patients without disease progression (p<0.02). 
CONCLUSION: Fatty acids of tissue phospholipids’ fraction, as well as SI, strongly 
depend on tumor localization and might be useful as potential markers of the 
disease progression in colorectal cancer patients.
INTRODUCTION
Colorectal tumors can be located within the 
proximal or distal part of intestine as well as in 
the rectum. The risk of developing colon cancer 
depends on environmental and genetic factors 
(Bufill 1990). Probability of 5 year survival rate is 
different for these three locations of the tumor and 
it is 13% less in patients with tumor located in the 
proximal part of intestine compared to patients 
with cancer located in the distal part of intestine 
(Wong 2010). At present, no tumor marker is 
known to assess colorectal cancer progression. 
Fatty acids play a critical role in several bio-
logical processes. The fluidity and permeability 
of the cell membranes and enzymes activity and 
membrane receptors activity largely depends on 
the type and amount of unsaturated fatty acids 
of phospholipids and esters of cholesterol. The 
increase of membrane fluidity leads to increase 
cells metabolism (Cooper 1977). There are many 
reports in the literature concerning on concentra-
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tion the fatty acids level in the blood serum of patients 
with colorectal cancer, but there is little data about the 
fatty acids content in colorectal cancer tissue. Proper 
ratio of saturated and unsaturated fatty acids in mem-
brane phospholipids is essential for permeability and 
fluidity of the cell membranes. Changes in fatty acids 
composition may influence on cell structure and func-
tion and may have a great impact on the cell prolifera-
tion. The levels of C18 and C18:1 in the erythrocytes 
cell membranes in patients with different types of 
cancer (breast, prostate, liver, pancreas, colon and lung) 
were investigated. Lower levels of C18 in patients with 
cancer and higher levels C18:1 as compared to patients 
without the cancer, have been demonstrated (Mikirova 
et al. 2004). According to some researchers, the ratio 
of these two fatty acids (index of fatty acids saturation, 
SI) in erythrocyte membranes of patients with different 
types of cancer did not differ significantly from SI for 
healthy subjects (Mikirova et al. 2004; Kelly et al. 1990). 
However, studies Kelly et al. (Kelly et al. 1990) have 
shown lower ratio of C18 to C18:1 in the membranes 
of erythrocytes in patients with colorectal cancer com-
pared with a control group. Very similar data to Kelly 
in patients with cancer of the gallbladder and patients 
with cancer of the prostate were observed (Pandey et al. 
1998; Persad et al. 1990). In contrast, Neoptolemos et 
al. (Neoptolemos et al. 1991) obtained a higher ratio of 
C18 to C18:1 in cancerous tissue compared to normal 
tissue in patients with colorectal cancer. 
The aim of this study was to assess the relation 
between tissue fatty acids (saturated fatty acids, unsatu-
rated fatty acids, SI), colorectal tumor localization and 
disease progression.
MATERIAL AND METHODS
Forty nine patients with colorectal cancer (26 men and 
23 women, mean age 63.5 ± 10.3 years) were selected 
from patients attending a tertiary care in University 
Hospital in Krakow, Poland. The clinical diagnosis 
was based on physical examination, colonoscopy, 
endorectal USG, abdominal CT, and histopathology of 
tissue specimens according to Astler-Coller classifica-
tion. Each patient underwent open surgery in order to 
remove the tumor. The patients with diabetes mellitus 
or glucose intolerance assessed based on fasting plasma 
glucose level and oral glucose tolerance test (OGTT) 
were excluded from the study. The study was approved 
by the local Ethical Committee (KBET/14/B/2006, 
resumed and expanded in 2013). According to UICC/
AJCC classification, 2 patients (4.1%) were in stage 0 
of the disease, 16 patients (32.7%) in stage I, 5 patients 
(10.2%) in stage II, 8 patients (16.3%) in stage III and 
18 patients (36.7%) in stage IV. In 14 patients (28.6%) 
the tumor was located in proximal colon, in 13 patients 
(26.5%) in distal colon and in 22 patients (44.9%) the 
tumor localization was confined to the rectum. After 
one year of follow up 25 patients (51%) were in stable 
condition and the remaining 24 patients (49%) had the 
disease progression. 
19 (38.8%) patients were normal weight 
(18.5≤BMI<24.99), 22 (44.9%) patients were over-
weight (25≤BMI<29.99) and 8 (16.3%) patients were 
obese I (30≤BMI<34.99).
Mucosa samples from malignant and adjacent 
unchanged tissue were taken from each patient intra-
operatively. Samples were frozen at -70°C. Measurement 
of fatty acids of phospholipids fraction was performed 
by following steps: 1) extraction of total lipids from tis-
sues homogenate by Folch et al. method (Folch, Lees, 
and Sloane Stanley 1957), 2) separation of lipid fractions 
using Sep-Pak NH2 columns (Waters, Milford, Mass., 
USA) (Kaluzny et al. 1985), 3) methylation of fatty acids 
(Kang and Wang 2005; Morrison and Smith 1964) and 4) 
determination of the fatty acids methyl esters using gas 
chromatography with Flame Ionization Detector – FID 
(Agilent Technologies 6890 Network GC System, Wilm-
ington, De., USA) equipped with Agilent J&W HP-88 
capillary column (100m, 0.250 mm, 0.20μm) (Bugajska 
et al. 2010). Tissue levels of saturated fatty acids (C12-
lauric, C14-myristic, C16-palmitic, C18-stearic) and 
unsaturated fatty acids (C16:1(n-7)-palmitooleic, 
C18:1(n-9)-oleic, C18:2(n-6)-linoleic, C20:4(n-6)-
arachidonic) were measured. These fatty acids were 
determined in cancerous tissue (CA) and non-cancer-
ous tissue (NCA). The method was calibrated using 
the calibration mixture (all fatty acids - Sigma-Aldrich, 
Steinheim, Germany). The results were expressed as the 
percentage of total tissue fatty acids. 
The sum of saturated fatty acids, the ratio of C18 
to C18:1 (SI) and the ratio of C16 to C16:1 were cal-
culated. The data are presented in the form of typical 
descriptive statistics (mean, SE). The Shapiro-Wilk’s 
test was used to determine the normality of data distri-
bution. To evaluate the differences within each group 
for every parameter, a repeated measurement one-way 
ANOVA test was performed. The Tukey test was used 
to compare groups. Statistical analyses were performed 
with Statistica 10. The level of statistical significance 
was established at p<0.05.
RESULTS
Among the fatty acids in all colorectal cancer patients 
without tumor progression the mean value of C18 in 
NCA was significantly higher as compared to patients 
with tumor progression (20.9±1.25; 16.0±1.28; respec-
tively; p<0.04). In contrast, the mean value of C18:1 in 
NCA was significantly lower in patients without tumor 
progression as compared to those with tumor progres-
sion (17.5±1.06; 22.08±1.09; respectively; p<0.006). The 
mean values of calculated parameter (C18/C18:1) in 
patients without tumor progression were significantly 
higher as compared to those with tumor progression 
both in NCA and CA (p<0.005; p<0.02; respectively) 
(Fig. 1).
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The most significant differences in the mean values 
of fatty acids of phospholipids between cancer tissue 
and non-cancerous tissue in patients with proximal 
tumor localization were noted. Among saturated fatty 
acids the mean value of C16 was significantly lower 
in CA as compared to NCA in patients with disease 
progression (29.7±1.8; 36.9±2.0; respectively; p<0.05), 
the mean value of C18 was significantly lower in CA 
as compared to NCA in patients without disease pro-
gression (19.9±1.8; 28.0±2.0; respectively; p<0.02) and 
the mean values of SFA were significantly lower in CA 
as compared to NCA in patients with and without dis-
ease progression (p<0.01; p<0.03; respectively) (Fig.2). 
In contrast, the mean value of C16:1 was significantly 
higher in CA as compared to NCA in patients with dis-
ease progression (1.5±0.2; 0.5±0.2; respectively; p<0.01) 
and C18:1 was significantly higher in CA as compared to 
NCA without disease progression (18.2±1.4; 12.9±1.5; 
respectively; p<0.03) in patients with proximal tumor 
localization. For distal colon and rectal tumor localiza-
tion, there were no differences for C18:1, but the mean 
value of C16:1 was significantly higher in CA as com-
pared to NCA both: in patients with disease progres-
sion as well as in patients without disease progression 
(p<0.02-0,04).
SI was significantly lower in CA as compared to 
NCA only in patients with proximal tumor localiza-
tion without disease progression (p<0.02) (Fig.1). The 
ratio of C16 to C16:1 was lower in CA as compared to 
NCA regardless of the tumor localization, but signifi-
cant difference was observed in patients with disease 
progression for proximal and distal tumor localization 
(p<0.007; p<0.002; respectively) and in patients with-
out disease progression for distal tumor localization 
(p<0.04) (Fig.3). 
Fig. 1. C18/C18:1 (saturation index – SI) in cancer tissue (CA) and 
non-cancerous tissue (NCA) in relation to tumor localization and 
cancer progression. 
Fig. 2. The sum of saturated fatty acids (SFA= C14+C16+C18), in 
cancer tissue (CA) and non-cancerous tissue (NCA) in relation to 
tumor localization and cancer progression. 
Fig. 3. C16/C16:1 in cancer tissue (CA) and non-cancerous tissue 
(NCA) in relation to tumor localization and cancer progression.
The mean values of C12, C14, C16 and C18 were 
similar in CA and NCA for patients with distal colon 
and rectal tumor localization. There were no significant 
differences between studied groups regarding the mean 
values of C18:2 and C20:4, however higher value was 
noted in CA as compared to NCA in patients with prox-
imal tumor localization independently of the cancer 
progression (Table 1).
There were no differences in BMI, depending 
on the tumor localization (proximal tumor local-
ization BMI=25±0.97; distal tumor localization 
BMI=26.4±0,97; rectum BMI=26.6±0,75).
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DISCUSSION 
Fatty acids are very important biological compounds 
which may be associated with different diseases includ-
ing metabolic diseases such as type 2 diabetes, inflam-
matory diseases (Calder 2015), depressive disorders 
(Vareka et al. 2012), autism (Sliwinski et al. 2006) or are 
linked with an increased risk of certain cancer. Litera-
ture evidences suggest that dietary lipids could play an 
important role within the context of colorectal cancer 
tumor localization although inconsistent results are fre-
quently seen (Hodge et al. 2015; Mo et al. 2018). The 
diet may contribute to reducing overall colorectal cancer 
and particularly rectal cancer risk. Dietary saturated 
fatty acids (stearic acid, palmitic acid) and monounsatu-
rated fatty acids (palmitoleic acid, oleic acid) were more 
strongly positively associated with rectal than colon 
cancer (Hodge et al. 2015). Dietary polyunsaturated 
fatty acids may be positively associated with risk early 
neoplasia in the proximal colon (Mo et al. 2018). There 
are reports in the literature concerning on diet, but there 
is little data about the fatty acids content in colorectal 
cancer tissue, therefore the main goal of the present 
study was to find out the relationship between the fatty 
acids composition in tissue phospholipids’ fraction, 
tumor localization and disease progression in colorectal 
cancer patients. Measurement of plasma phospholipids 
fatty acids is more common and can be considered as the 
most useful because a correlation exists between dietary 
fatty acid intake and the proportion of fatty acids in 
plasma in cancerous diseases and other non-cancerous 
diseases (Vareka et al. 2012; Sliwinski et al. 2006). To 
our knowledge, this is the first report of an association 
between levels of fatty acids of tissue phospholipids in 
the cancer tissue and non-cancerous tissue in relation 
to tumor localization and colorectal cancer progression. 
Only fatty acids of total lipids from colorectal cancer 
tissue were investigated (Neoptolemos et al. 1991; Fer-
nandez-Banares et al. 1996). The levels of cell membrane 
fatty acids in the colorectal tumors and non-malignant 
colonic mucosa were compared only in rats (Nicholson 
et al. 1991). In the present study the fatty acids of phos-
pholipids’ fraction were studied because they are the 
most sensitive indicators of fatty acids fluctuations. 
The evidence was presented that colorectal cancer 
cases should be divided into proximal colon cancer, 
distal colon cancer and rectal cancer by showing differ-
ences in physiology and anatomy, environmental car-
cinogens, genetic mechanism and prognosis between 
these three cancer location (Li and Lai 2009; Iacopetta 
2002). In the large retrospective cohort study in US sig-
nificantly lower 5-year survival for patients with proxi-
mal colon cancer compared to distal colon cancer was 
demonstrated (Wong 2010). In the present study the 
biggest changes of fatty acids were observed in patients 
with proximal tumor localization. 
Decreased membrane rigidity is one of the charac-
teristic attribute of malignant cells, resulting in part 
from the desaturation of stearic acid into oleic acid. 
The study of Habib et al. (Habib et al. 1987) demon-
strated that treatment with stearic acid inhibits tumor 
development in rats. The SI in erythrocyte membranes 
was significantly reduced in the tumor bearing rats, but 
was normal in tumor-free animals treated with stearic 
acid. Decrease SI in erythrocyte membranes of patients 
with prostatic carcinoma and colorectal carcinoma has 
reported (Kelly et al. 1990; Persad et al. 1990). Simi-
lar findings in the phospholipids’ fraction of prostatic 
tissue of patients with benign and malignant prostatic 
disease were observed (Chaudry et al. 1991). Freeman 
et al. (Freeman et al. 2007) and Kositsawat et al. (Kosit-
sawat et al. 2007) showed that the oleic-to-stearic acid 
ratio of total lipids in the prostate tissue predicted the 
risk of biochemical failure following radical prostatec-
tomy for clinically localized prostate cancer. 
In our study, in patients with proximal tumor 
localization without disease progression the signifi-
cantly decreased value of stearic acid and SI in CA as 
compared to NCA were noticed. These changes were 
accompanied by increased the value of oleic acid.
Human organism can synthesize all fatty acids except 
two: linoleic acid (LA) and α-linolenic acid, known as 
‘essential fatty acids’. LA is the precursor to the higher 
unsaturated n-6 series of fatty acids (arachidonic acid, 
Tab. 1. Percentage of fatty acids: C18:2; C20:4 in cancer tissue (CA) and non-cancerous tissue (NCA) in relation to tumor localization and 
cancer progression. 
all patients
Tumor localization
Fatty acid
proximal colon distal colon rectum
NCA CA NCA CA NCA CA NCA CA
% of total, mean ± SE
C 18:2 
8.5±0.6 8.6±0.6 6.4±1.4 8.2±1.2 10.5±0.7 11.5±0.8 8.1±0.6 7,4±0,6
9.3±0.8 9.3±0.8 6.4±1.0 8.7±0.9 12.0±1.8 9.0±1.9 9.1±1.0 9,9±1,1
C 20:4
16.5±0.8 16.3±0.8 12.6±1.6 17.4±1.5 16.1±1.8 15.5±1.9 18.1±0.9 16,2±0,9
16.7±1.0 17.3±1.1 11.0±1.8 15.3±1.6 17.8±1.5 16.1±1.6 19.7±1.3 19.9±1.3
 – disease progression,  – no disease progression 
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C20:4, AA). AA is the precursor of putative cancer pro-
moting prostaglandins. Nicholson et al. (Nicholson et 
al. 1991) found in rats high values of arachidonic acid 
in cell membrane in the colorectal tumors compared 
to colonic mucosa. Also Neoptolemos et al. (Neoptol-
emos et al. 1991) showed the increased value of AA of 
total lipids from colorectal cancer tissue as compared 
to normal mucosa. However, in other study there were 
no significant differences in values of AA and LA of 
total lipids tissue between colorectal cancer tissue and 
normal mucosa (Fernandez-Banares et al. 1996). Our 
study showed the higher content of AA and LA in CA 
as compared to NCA in patients with proximal tumor 
localization. 
In conclusion, the results of the study are prelimi-
nary, but they suggest that fatty acids of tissue phospho-
lipids’ fraction, as well as SI, strongly depend on tumor 
localization. It should be taken into account while con-
sidering these markers as a potential factor of the dis-
ease progression in colorectal cancer patients.
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